BOOK
Rapid Geriatric Assessment, An Issue of Clinics in Geriatric Medicine, E-Book
(2017)
Additional Information
Book Details
Abstract
This issue of Clinics in Geriatric Medicine, guest edited by Dr. John Morley, is devoted to Rapid Geriatric Assessment. Articles in this issue will address Frailty; Sarcopenia; Anorexia of Aging; Mild Cognitive Impairment; Cognitive Frailty; Falls; Hip Fracture; Depression; Delirium; and Advanced Directives and Palliative Care.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Rapid Geriatric\rAssessment\r | i | ||
Copyright\r | ii | ||
Contributors | iii | ||
EDITOR | iii | ||
AUTHORS | iii | ||
Contents | vii | ||
Preface: The New Geriatric Giants | vii | ||
Frailty in Older Persons | vii | ||
Sarcopenia | vii | ||
Anorexia of Aging: Assessment and Management | vii | ||
Mild Cognitive Impairment | vii | ||
Cognitive Frailty: Mechanisms, Tools to Measure, Prevention and Controversy\r | viii | ||
Falls in the Aging Population | viii | ||
Rapid Geriatric Assessment of Hip Fracture | viii | ||
Rapid Depression Assessment in Geriatric Patients | viii | ||
Dissecting Delirium: Phenotypes, Consequences, Screening, Diagnosis, Prevention, Treatment, and Program Implementation | ix | ||
Integrating Quality Palliative and End-of-Life Care into the Geriatric Assessment: Opportunities and Challenges | ix | ||
Rapid Geriatric Assessment: Secondary Prevention to Stop Age-Associated Disability | ix | ||
CLINICS IN GERIATRIC MEDICINE\r | x | ||
FORTHCOMING ISSUES | x | ||
November 2017 | x | ||
February 2018 | x | ||
RECENT ISSUES | x | ||
May 2017 | x | ||
February 2017 | x | ||
Preface:\rThe New Geriatric Giants | xi | ||
REFERENCES | xi | ||
Frailty in Older Persons | 293 | ||
Key points | 293 | ||
INTRODUCTION | 293 | ||
WHAT FRAILTY IS | 294 | ||
THE RELATIONSHIP BETWEEN FRAILTY AND DISABILITY | 295 | ||
THE ASSESSMENT OF FRAILTY | 295 | ||
THE MANAGEMENT OF FRAILTY | 297 | ||
SPECIFIC ISSUES IN THE MANAGEMENT OF FRAILTY | 299 | ||
SUMMARY | 300 | ||
REFERENCES | 300 | ||
Sarcopenia | 305 | ||
Key points | 305 | ||
INTRODUCTION | 305 | ||
DEFINITION | 306 | ||
PREVALENCE (REVERSIBILITY) | 306 | ||
ETIOLOGY | 306 | ||
CONSEQUENCES | 307 | ||
OTHER CLOSELY RELATED SYNDROMES AND DISEASES | 308 | ||
DIAGNOSIS | 309 | ||
TREATMENT (NONPHARMACEUTICAL AND PHARMACEUTICAL) | 310 | ||
Nonpharmaceutical | 310 | ||
Nutrition | 310 | ||
Exercise | 310 | ||
Pharmaceutical | 311 | ||
REFERENCES | 312 | ||
Anorexia of Aging | 315 | ||
Key points | 315 | ||
INTRODUCTION | 315 | ||
ANOREXIA OF AGING: THE BIOLOGICAL SUBSTRATE | 316 | ||
RISK FACTORS | 317 | ||
ASSESSMENT AND MANAGEMENT OF ANOREXIA OF AGING | 318 | ||
TREATMENT OPTIONS FOR ANOREXIA OF AGING | 320 | ||
SUMMARY | 321 | ||
REFERENCES | 321 | ||
Mild Cognitive Impairment | 325 | ||
Key points | 325 | ||
INTRODUCTION | 325 | ||
EPIDEMIOLOGY | 326 | ||
PATHOPHYSIOLOGY | 327 | ||
REVERSIBLE CAUSES | 327 | ||
SCREENING AND DIAGNOSIS | 329 | ||
Screening Instruments | 329 | ||
Imaging Studies and Biomarkers | 331 | ||
Why Is Early Diagnosis Important? | 332 | ||
TREATMENT | 332 | ||
SUMMARY | 334 | ||
REFERENCES | 334 | ||
Cognitive Frailty | 339 | ||
Key points | 339 | ||
INTRODUCTION | 339 | ||
THE COGNITIVE FRAILTY APPROACH | 340 | ||
The Proposed Definition of Cognitive Frailty | 340 | ||
The History of the Link Between Frailty and Cognitive Impairment | 340 | ||
The Relationship Between Frailty and Cognition | 341 | ||
THE MECHANISMS OF COGNITIVE FRAILTY | 341 | ||
Cardiovascular Risk Factors | 341 | ||
Nutrition | 345 | ||
Hormonal Changes | 346 | ||
Inflammation | 346 | ||
Accumulation of Neurotoxic β-Amyloid in the Brain | 346 | ||
Nigral Neuronal Loss | 346 | ||
Lifestyle and Mental Health Issues | 347 | ||
THE TOOLS TO MEASURE COGNITIVE FRAILTY | 347 | ||
THE PREVENTION OF COGNITIVE FRAILTY | 348 | ||
COGNITIVE FRAILTY CONTROVERSY | 348 | ||
SUMMARY | 349 | ||
REFERENCES | 349 | ||
Falls in the Aging Population | 357 | ||
Key points | 357 | ||
INTRODUCTION | 357 | ||
PREVALENCE, LOCATION, AND CONSEQUENCES | 358 | ||
RISK FACTORS FOR FALLS | 359 | ||
Sensory Impairment | 359 | ||
Sedentary Behavior | 360 | ||
Frailty, Nutrition, and Oral Health | 360 | ||
Cognition and Mood Disorders | 360 | ||
Gait, Balance, and Neurologic Impairment | 360 | ||
Comorbid Illness | 361 | ||
SCREENING AND ASSESSMENT OF FALLS | 361 | ||
Low Risk | 361 | ||
High Risk | 362 | ||
Falls history | 362 | ||
Functional and continence assessment | 362 | ||
Nutrition, appetite, and sarcopenia assessment | 362 | ||
Cognition and mood | 362 | ||
Fracture risk assessment | 362 | ||
Medications review | 363 | ||
Frailty | 363 | ||
Comprehensive physical examination | 363 | ||
Home and environmental assessment | 364 | ||
Laboratory and imaging investigations | 364 | ||
INTERVENTIONS FOR FALLS PREVENTION | 364 | ||
SUMMARY | 364 | ||
ACKNOWLEDGMENTS | 364 | ||
REFERENCES | 364 | ||
Rapid Geriatric Assessment of Hip Fracture | 369 | ||
Key points | 369 | ||
PREOPERATIVE ASSESSMENT | 369 | ||
Timing of Surgery | 370 | ||
Components of the Preoperative Assessment | 370 | ||
History | 370 | ||
Cognition | 370 | ||
Physical examination and pain | 371 | ||
Nutrition | 372 | ||
Surgical risk | 372 | ||
Comorbidities and frailty | 372 | ||
Medication review | 373 | ||
Investigations | 374 | ||
Preoperative anemia | 375 | ||
Imaging | 375 | ||
Preoperative indicators of mortality and morbidity | 375 | ||
SUMMARY | 377 | ||
REFERENCES | 377 | ||
Rapid Depression Assessment in Geriatric Patients | 383 | ||
Key points | 383 | ||
INTRODUCTION | 383 | ||
SCREENING FOR DEPRESSION | 384 | ||
Waiting Room | 384 | ||
Clinical Encounter | 384 | ||
Suicidality | 385 | ||
Depression with Psychotic Symptoms | 386 | ||
Medication-Induced Depression | 387 | ||
Medical Comorbidities | 388 | ||
Cardiac Comorbidities | 388 | ||
Endocrine Disorders | 388 | ||
Neurologic or Psychiatric Comorbidities | 388 | ||
REFERENCES | 389 | ||
Dissecting Delirium | 393 | ||
Key points | 393 | ||
INTRODUCTION | 394 | ||
DEFINITION AND PHENOTYPES OF DELIRIUM | 394 | ||
PREVALENCE AND INCIDENCE | 394 | ||
CONSEQUENCES | 394 | ||
DESPITE THE MORBIDITY AND MORTALITY, DELIRIUM IS IGNORED BY HEALTH CARE | 396 | ||
DIAGNOSIS AND SCREENING: KEY COGNITIVE PROCESSES FOR DELIRIUM | 396 | ||
Consciousness | 396 | ||
Attention | 397 | ||
Delirium Diagnosis | 397 | ||
“Rapid” Delirium Screening | 397 | ||
Screening for Delirium with Arousal: Area of Controversy | 398 | ||
CAUSES | 398 | ||
NEUROPATHOPHYSIOLOGY | 399 | ||
PHARMACOLOGIC PREVENTION AND TREATMENT OF DELIRIUM | 400 | ||
NONPHARMACOLOGIC PREVENTION AND TREATMENT | 406 | ||
Educational Programs | 406 | ||
Multicomponent Nonpharmacologic Prevention | 406 | ||
Single Component Nonpharmacologic Prevention | 406 | ||
Prevention of Delirium in Older People in Institutional Long-Term Care | 406 | ||
Nonpharmacologic Treatment | 408 | ||
THE FUTURE OF DELIRIUM | 408 | ||
SUMMARY | 409 | ||
REFERENCES | 409 | ||
Integrating Quality Palliative and End-of-Life Care into the Geriatric Assessment | 415 | ||
Key points | 415 | ||
INTRODUCTION | 415 | ||
SCOPE AND DEFINITION OF PALLIATIVE AND END-OF-LIFE CARE | 416 | ||
QUALITY OF DEATH | 417 | ||
PROGNOSTICATION | 417 | ||
THE TRANSITION FROM CURATIVE TO PALLIATIVE CARE | 419 | ||
DETERMINING LIFE EXPECTANCY | 420 | ||
PALLIATIVE CLINICAL CARE | 423 | ||
CLINICAL CARE AT THE END OF LIFE | 425 | ||
SUMMARY | 427 | ||
REFERENCES | 428 | ||
Rapid Geriatric Assessment | 431 | ||
Key points | 431 | ||
THE PHYSICAL FRAILTY PHENOTYPE | 432 | ||
SARCOPENIA | 433 | ||
SIMPLIFIED NUTRITIONAL ASSESSMENT QUESTIONNAIRE | 433 | ||
RAPID COGNITIVE SCREEN | 434 | ||
ADVANCE DIRECTIVES | 434 | ||
SUMMARY | 434 | ||
REFERENCES | 435 | ||
Index | 441 |